Language
English
Publication Date
4-1-2026
Journal
Nature Microbiology
DOI
10.1038/s41564-026-02285-8
PMID
41840216
PMCID
PMC13056551
PubMedCentral® Posted Date
3-16-2026
PubMedCentral® Full Text Version
Post-print
Abstract
Azithromycin is a widely used antibiotic and was frequently used to treat hospitalized patients during the COVID-19 pandemic. The impact of empiric azithromycin use on the respiratory microbiome in patients with viral respiratory infections is unclear. Here we used longitudinal metatranscriptomics on nasal swabs from a prospective multicentre cohort of 1,164 patients hospitalized for COVID-19. We compared the upper respiratory microbiome, resistome and systemic immune response in patients treated with azithromycin (n = 366) with those who received no antibiotics (n = 474) or other antibiotics (n = 324). We found that azithromycin altered microbiome composition and increased the expression and relative proportion of macrolide/lincosamide/streptogramin (MLS) resistance genes. These changes occurred after 1 day of exposure and persisted for over a week. MLS resistance gene expression was associated with commensals and potential pathogens, while there were no differences in host inflammatory gene expression in blood and airways. This demonstrates that empiric azithromycin treatment impacts the upper respiratory microbiome and resistome without apparent anti-inflammatory benefit.
Keywords
Humans, Azithromycin, Anti-Bacterial Agents, Microbiota, Female, Male, SARS-CoV-2, Prospective Studies, COVID-19, Middle Aged, Respiratory System, COVID-19 Drug Treatment, Anti-Inflammatory Agents, Aged, Pandemics, Bacteria, Metagenomics, Clinical microbiology, Viral infection, Microbiome
Published Open-Access
yes
Recommended Citation
Glascock, Abigail; Maguire, Cole; Phan, Hoang Van; et al., "Empiric Azithromycin Alters the Upper Respiratory Microbiome and Resistome Without Anti-Inflammatory Benefit in COVID-19" (2026). Faculty, Staff and Students Publications. 7448.
https://digitalcommons.library.tmc.edu/baylor_docs/7448